Surprisingly, BAFF did not support the survival of BAFFR+ B-lymphoblasts, but it seemed to increase in a dose-independent manner the cell death of BAFFR+ pre-B-ALL cells from adult patients carrying the BCR-ABL rearrangement (Figure 4A). This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.